DreaMed Expands Its Remote Diabetes Solution to Four Clinics Across The U.S.

TEL AVIV, Israel–(BUSINESS WIRE)–Sep 30, 2020– DreaMed Diabetes Ltd., the developer of the personalized, AI-based…

DreaMed Expands Its Remote Diabetes Solution to Four Clinics Across The U.S.

TEL AVIV, Israel–(BUSINESS WIRE)–Sep 30, 2020–

DreaMed Diabetes Ltd., the developer of the personalized, AI-based diabetes management solutions, announces its expansion across the U.S. through partnerships with a number of health clinics. The partnerships signal the active integration of DreaMed Advisor, a cloud-based remote insulin management technology into various clinics, including: Lucile Packard Children’s Hospital Stanford, the Billings Clinic in Montana, Hassenfeld Children’s Hospital at NYU Langone and UF Health. These clinics, situated across the country, will embed DreaMed Advisor into their current protocols, helping them to provide diabetes patients with a personalized treatment solution.

According to the ADA, 1.25 million Americans have Type 1 diabetes, with an estimated 40,000 people receiving a type 1 diagnosis each year in the United States. Whether you’re residing in an urban metropolis or a rural heartland, managing diabetes remains a significant burden, both financially and logistically. Furthermore, due to the sheer size of the United States, many people with diabetes lack the necessary medical support required, particularly access to endocrinologists who provide them with critical guidance and information. The recent pandemic has also accelerated the need for solutions and initiatives to address our current predicament. That’s where DreaMed steps in.

The clinics involved will implement DreaMed’s diabetes protocol, integrating the DreaMed Advisor Pro software into their protocols. The Advisor Pro provides patients with personalized optimization of their insulin therapy management, driven by cloud-based technology utilizing artificial intelligence for swift data analysis and swift treatment. Recommendations are based on analysis of information derived from CGM, glucometers, insulin pumps, and the use of event-oriented data. As DreaMed expands across the U.S., an increasing number of patients will benefit from its AI-based diabetes management solution.

“It’s wonderful to see our remote diabetes solution being rolled out in so many clinics across the country, particularly at a time when people need it most.” says Eldad Postan-Koren, COO of DreaMed Diabetes. “Our mission is, and always will be, to provide people with diabetes and their health care professionals with a reliable, insulin-therapy management tool that enables the best care possible-wherever they are.”

About DreaMed Diabetes
DreaMed Diabetes is a medical device company providing personalized diabetes treatment optimization solutions. The company was established in 2014 and commercialized its first product, GlucoSitter, an artificial pancreas technology which was licensed to Medtronic Diabetes. Ever since, DreaMed Diabetes has been vigorously working on the DreaMed Advisor portfolio, decision support tools in the diabetes management space. DreaMed became the first and only company in the world to receive a CE Mark and FDA clearance for DreaMed Advisor Pro, a decision support system in Type I diabetes patients using data from CGM/SMBG and insulin pumps. The company is continuing to develop the DreaMed Advisor portfolio which will aid all people living with diabetes no matter the insulin therapy or diabetes type and their healthcare professionals to provide personalized insulin therapy. For more information please visit https://dreamed-diabetes.com/

About Billings Clinic
Billings Clinic is Montana’s largest health system serving Montana, Wyoming and the western Dakotas. A not-for-profit organization led by a physician CEO, Billings Clinic is governed by a board of community members, nurses and physicians. At its core, Billings Clinic is a physician-led, integrated multispecialty group practice with a 304-bed hospital and Level II trauma center. Billings Clinic has more than 4,300 employees, including more than 430 physicians and advanced practitioners offering more than 80 specialties. More information can be found at www.billingsclinic.com.

About Hassenfeld Children’s Hospital at NYU Langone
NYU Langone Health is a world-class, patient-centered, integrated academic medical center, known for its excellence in clinical care, research, and education. Included in its 350+ locations throughout the New York area are six inpatient locations: Tisch Hospital , its flagship acute-care facility; Kimmel Pavilion, its state-of-the-art healthcare facility, opened in 2018; NYU Langone Orthopedic Hospital, a dedicated inpatient orthopedic hospital with all musculoskeletal specialties ranked top 10 in the country; Hassenfeld Children’s Hospital at NYU Langone, a comprehensive pediatric hospital supporting a full array of children’s health services; NYU Langone Hospital—Brooklyn, a full-service teaching hospital and level 1 trauma center located in Sunset Park, Brooklyn; and NYU Winthrop Hospital, a 591-bed hospital and level 1 trauma center located in Mineola, Long Island. For more information, visit https://nyulangone.org/

University of Florida Clinic
UF Health is the Southeast’s most comprehensive academic health center. With main campuses in Gainesville and Jacksonville, UF Health includes six health colleges, nine research institutes and centers, two teaching hospitals, eight specialty hospitals and a host of physician medical practices and outpatient services throughout North Central Florida, Central Florida and Northeast Florida. Its mission is to promote health through outstanding and high-quality patient care, innovative and rigorous education in the health professions and biomedical sciences, and high-impact research across the spectrum of basic, translational and clinical investigation. For more information, visit https://ufhealth.org/

View source version on businesswire.com:https://www.businesswire.com/news/home/20200930005419/en/

CONTACT: Media Contact

Tahli Hanuka

ReBlondefor DreaMed Diabetes

[email protected]



SOURCE: DreaMed Diabetes

Copyright Business Wire 2020.

PUB: 09/30/2020 09:00 AM/DISC: 09/30/2020 09:00 AM